share_log

Puma Biotechnology Says NCCN Clinical Practice Adds Breast Cancer Drug Nerlynx to Guidelines

Puma Biotechnology Says NCCN Clinical Practice Adds Breast Cancer Drug Nerlynx to Guidelines

彪馬生物技術稱 NCCN 臨床實踐將乳腺癌藥物 Nerlynx 添加到指南中
MT Newswires ·  2023/02/01 16:14

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論